-
How accurate is chest imaging for diagnosing COVID‐19?Why is this question important?People with suspected COVID‐19 need to know quickly whether they are infected, so they can receive appropriate treatment, self‐isolate, and inform close contacts.Currently, a formal diagnosis of COVID‐19 requires a laboratory test (RT‐PCR) of nose and throat...
May 17 2022
-
During April 2022, the CIDG published one new protocol and one new review in Issue 4, 2022 of the Cochrane Database of Systematic Reviews.New Protocol Reis S, Popp M, Kuehn R, Metzendorf M-I, Gagyor I, Kranke P, Meybohm P, Skoetz N, Weibel S. Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19. Cochrane Database of...
April 28 2022
-
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the launch of Xpert MTB/RIF, which gives results in less than two hours, simultaneously diagnosing tuberculosis and testing if the bacteria have...
April 26 2022
-
An exciting opportunity has arisen in LSTM's Clinical Sciences team for an experienced Research Associate to join us. The Role:LSTM’s Centre for Evidence Synthesis in Global Health runs the “Research, Evidence and Development Initiative” (READ-It) and contains the Cochrane Infectious Diseases Group (CIDG).The CIDG was established in...
April 19 2022
-
Why is improving screening for tuberculosis of the lungs important?Systematic screening in settings where tuberculosis is common is a recommended strategy for early detection of tuberculosis. Screening helps identify people who are more likely to have tuberculosis so they can have confirmatory testing. These are additional tests to confirm the...
March 24 2022
-
Cochrane reviews on tests for tuberculosis disease and tuberculosis drug resistanceWith its editorial base at LSTM, Cochrane Infectious Diseases joins the global community in recognizing World TB Day with a Special Collection of systematic reviews on tests for tuberculosis disease and tuberculosis drug resistance. World...
March 24 2022
-
The Cochrane Infectious Diseases Group Review of Hydroxychloroquine for COVID-19 has been recognised with the inaugural Harding Prize for Useful and Trustworthy Communication. The £3,141 prize was launched to celebrate individuals or teams liaising on information which helps inform policies or procedures. It was judged by five experts,...
March 17 2022
-
During March 2022, the CIDG published two new reviews in Issue 3, 2022 of the Cochrane Database of Systematic Reviews, and published an updated Cochrane Special Collection on diagnosing tuberculosis. In addition, the CIDG review on hydroxychloroquine for COVID-19 was the joint winner of the inaugural Harding Prize for Useful and Trustworthy...
March 12 2022
-
We talk with highly-valued former staff member Dr Marylou Murray, who worked with the READ-It team as a Clinical Research Associate and CIDG author from January 2019 to January 2020 What Marylou did before joining Cochrane Infectious Diseases Group (CIDG)With 14 years in rural general practice, Dr Marylou Murray sought to develop her experience...
March 8 2022
-
Mass drug administration means giving every person living in a village or region a drug, irrespective of whether they have the disease or not. It’s an approach used in some disease control programmes in Africa, Asia, and South America since the 1930s. They are often steeped in controversy: some specialists believing they are effective, whilst...
February 17 2022
How accurate is chest imaging for diagnosing COVID‐19?Why is this question important?People with suspected COVID‐19 need to know quickly whether they are infected, so they can receive appropriate treatment, self‐isolate, and inform close contacts.Currently, a formal diagnosis of COVID‐19 requires a laboratory test (RT‐PCR) of nose and throat...May 17 2022
During April 2022, the CIDG published one new protocol and one new review in Issue 4, 2022 of the Cochrane Database of Systematic Reviews.New Protocol Reis S, Popp M, Kuehn R, Metzendorf M-I, Gagyor I, Kranke P, Meybohm P, Skoetz N, Weibel S. Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19. Cochrane Database of...April 28 2022
An exciting opportunity has arisen in LSTM's Clinical Sciences team for an experienced Research Associate to join us. The Role:LSTM’s Centre for Evidence Synthesis in Global Health runs the “Research, Evidence and Development Initiative” (READ-It) and contains the Cochrane Infectious Diseases Group (CIDG).The CIDG was established in...April 19 2022
Why is improving screening for tuberculosis of the lungs important?Systematic screening in settings where tuberculosis is common is a recommended strategy for early detection of tuberculosis. Screening helps identify people who are more likely to have tuberculosis so they can have confirmatory testing. These are additional tests to confirm the...March 24 2022
Cochrane reviews on tests for tuberculosis disease and tuberculosis drug resistanceWith its editorial base at LSTM, Cochrane Infectious Diseases joins the global community in recognizing World TB Day with a Special Collection of systematic reviews on tests for tuberculosis disease and tuberculosis drug resistance. World...March 24 2022
The Cochrane Infectious Diseases Group Review of Hydroxychloroquine for COVID-19 has been recognised with the inaugural Harding Prize for Useful and Trustworthy Communication. The £3,141 prize was launched to celebrate individuals or teams liaising on information which helps inform policies or procedures. It was judged by five experts,...March 17 2022
We talk with highly-valued former staff member Dr Marylou Murray, who worked with the READ-It team as a Clinical Research Associate and CIDG author from January 2019 to January 2020 What Marylou did before joining Cochrane Infectious Diseases Group (CIDG)With 14 years in rural general practice, Dr Marylou Murray sought to develop her experience...March 8 2022